AstraZeneca And Daiichi Sankyo Pull Dato-DXd File in EU On Heels Of US Switch

Futuristic medical concept with blue human lungs
AstraZeneca used a proprietary AI-based model to analyze TROP2 expression • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Immuno-oncology

More from Business